SEARCH

SEARCH BY CITATION

Keywords:

  • chemotherapy;
  • renal medullary carcinoma;
  • sickle cell trait

Abstract

Most patients with renal medullary carcinoma (RMC) have advanced disease at presentation and rarely respond to radiation or chemotherapy. We describe two adolescents with metastatic disease who had significant responses to cisplatin or carboplatin in combination with gemcitabine and paclitaxel. © 2004 Wiley-Liss, Inc.